CLSD - Clearside Biomedical, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5555
Avg. Estimate-0.14-0.15-0.58-0.6
Low estimate-0.15-0.16-0.6-0.66
High estimate-0.12-0.13-0.54-0.53
Year ago EPS-0.13-0.13-0.55-0.58
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts4443
Avg. Estimate150k160k500k6.39M
Low estimateN/AN/AN/A600k
High estimate350k350k1.05M9.61M
Year ago sales384k6.52M1.33M500k
Sales growth (year/est)-60.90%-97.50%-62.30%1,178.00%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.13-0.03-0.13-0.14
Actual EPS-0.13-0.13-0.16-0.15
Difference0-0.1-0.03-0.01
Surprise %0.00%-333.30%-23.10%-7.10%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.14-0.15-0.58-0.6
7 days ago-0.14-0.15-0.58-0.6
30 days ago-0.14-0.15-0.58-0.62
60 days ago-0.14-0.15-0.58-0.64
90 days ago-0.15-0.16-0.61-0.68
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2114
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLSDIndustrySector(s)S&P 500
Current qtr.-7.70%N/AN/AN/A
Next qtr.-15.40%N/AN/AN/A
Current year-5.50%N/AN/AN/A
Next year-3.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A